(Press-News.org) Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's. This is the main conclusion of a study published in the Nature in which has collaborated the researcher Isidro Ferrer, head of the group of Neuropathology at the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital and Full Professor of Pathological Anatomy at the University of Barcelona. The research was led by researchers from the International School for Advanced Studies (SISSA) in Trieste (Italy).
The collaboration of the research group led by Dr. Ferrer with SISSA researchers began five years ago when they observed that Parkinson's patients showed a deficit in UCHL1 protein. At that time, researchers didn't know what mechanism produced this deficit. To discover it a European project was launched. It was coordinated by the Italian researchers and participated by other European research groups, including the group led by Dr. Ferrer. The project, called Dopaminet, focused on how dopaminergic neurons (brain cells whose neurotransmitter is dopamine) are involved in Parkinson's disease.
Contrary to most common hypothesis that a DNA fragment encodes a protein through a messenger RNA molecule, the researchers found that it also works in reverse. They found a balance between the protein and its mirror protein, which is configured in reverse, and they are mutually controlled. If the protein mirror is located in the nucleus of the cell, it does not interact with the protein, while if it is in the cytoplasm, then both of them interact.
In the case of Parkinson's disease the protein UCHL1 appears reduced and also its mirror protein is localized in the nucleus, and in the cytoplasm. Thus, the researchers sought a method to extract the mirror protein from the nucleus and made it interact with the original UCHL1 protein. The authors found that rapamycin was able to extract them from the nucleus. The drug allows the two proteins, the UCHL1 and its mirror, hold together in the cytoplasm, which would correct the mistakes that occur in Parkinson's disease.
This in vitro research has allowed describing a new unknown mechanism. It is necessary that the UCHL1 mirror protein should accumulate in the nucleus and escape from the cytoplasm and join the UCLH1 protein. The combination of both makes the system work.
"The rapamycin can not cure Parkinson's disease, but it may delay the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's itself. Rapamycin can protect and delay the beginning of these diseases. It can complete the treatment, but it should be combined with other existing treatments", explains Isidro Ferrer.
Anyway, it is still far its application in patients. The next step is to validate these results in animal models and study the effects of rapamycin in combination with other drugs.
### About Us
The Bellvitge Biomedical Research Institute (IDIBELL) is a research center created in 2004 and it is participated by the Bellvitge University Hospital, the Catalan Institute of Health, the Catalan Institute of Oncology, and the University of Barcelona. IDIBELL is located at Biopol'H at L'Hospitalet de Llobregat and is member of the Health Universtitat de Barcelona Campus.
Article reference
Claudia Carrieri, Laura Cimatti, Marta Biagioli, Anne Beugnet, Silvia Zucchelli, Stefania Fedele, Elisa Pesce,Isidre Ferrer, Licio Collavin, Claudio Santoro, Alistair R. R. Forrest, Piero Carninci, Stefano Biffo, Elia Stupka & Stefano Gustincich. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature. DOI: 10.1038/nature11508
An immunosuppressive drug could delay the onset of neurodegenerative diseases
Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of diseases such as Alzheimer's or Parkinson's
2012-10-15
ELSE PRESS RELEASES FROM THIS DATE:
Bicycle helmets prevent fatal head injuries
2012-10-15
Cyclists who died of a head injury were three times as likely to not be wearing a helmet compared with those who died of other injuries, according to a study in CMAJ (Canadian Medical Association Journal).
"We saw an association between dying as a result of sustaining head injury and not wearing a helmet," states Dr. Navindra Persaud, Keenan Research Centre and the Department of Family and Community Medicine, St. Michael's Hospital, Toronto, with coauthors. "These results are consistent with a protective effect of helmets on cycling deaths."
There is scant evidence ...
'Mother's kiss' safe and effective for removing foreign objects from children's noses
2012-10-15
A technique called the "mother's kiss" for removing foreign objects from the nasal passages of young children appears to be a safe and effective approach, found a study published in CMAJ (Canadian Medical Association Journal).
"The mother's kiss appears to be a safe and effective technique for first-line treatment in the removal of a foreign body from the nasal cavity," writes Dr. Stephanie Cook, Buxted Medical Centre, Buxted, United Kingdom, with coauthors. "In addition, it may prevent the need for general anesthesia in some cases."
The technique, known since the ...
Scratching the surface of psoriasis
2012-10-15
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate. In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. These results indicate that IL-36 ...
JCI early table of contents for Oct. 15, 2012
2012-10-15
Scratching the surface of psoriasis
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate. In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. ...
Mice at risk of asthma, allergies can fight off skin cancer
2012-10-15
A molecule involved in asthma and allergies has now been shown to make mice resistant to skin cancer, according to scientists at Washington University School of Medicine in St. Louis.
The molecule, called TSLP (thymic stromal lymphopoietin), is produced by damaged skin and activates the immune system. Chronic low levels of TSLP are suspected in making the immune system oversensitive to what should be a harmless environment, leading to the skin rashes and overproduction of mucus common in allergies and asthma.
"But at extremely high levels, TSLP appears to train the ...
New approaches in the treatment of alcohol dependence
2012-10-15
"Addiction is a brain disease" was the title of an editorial in the renowned journal "Science" 15 years ago. The author argued that recognising addiction as a disorder of the brain can impact society´s overall health and social policy strategies and help diminish the health and social costs associated with drug abuse and addiction (Leshner, 1997). Such a presentation of the complex concept of addiction was revolutionary, as social and psychological aspects were largely considered as the most important, although not the only ones involved.
Some years later, clinicians ...
Study sheds light on role of exercise and androgens such as testosterone on nerve damage repair
2012-10-15
A study by researchers from Emory University and Indiana University found that the beneficial effects daily exercise can have on the regeneration of nerves also require androgens such as testosterone in both males and females. It is the first report of both androgen-dependence of exercise on nerve regeneration and of an androgenic effect of exercise in females.
"The findings will provide a basis for the development of future treatment strategies for patients suffering peripheral nerve injuries," said Dale Sengelaub, professor in the Department of Psychological and Brain ...
University of Tennessee study confirms solar wind as source for moon water
2012-10-15
Three years ago University of Tennessee, Knoxville, researchers helped to discover water on the surface of the moon. Now, they are piecing together the origin of that water: solar wind.
A new study confirms solar wind as a source for water embedded in the lunar surface.
Solar wind is the continuous flow of charged particles from the sun. Scientists have speculated it to be responsible for water on the surface of the moon.
Last year Larry Taylor, distinguished professor in the Department of Earth and Planetary Sciences, confirmed comets as the source for water ...
LA BioMed's Dr. Virender Rehan studies maternal nicotine's effects on unborn children and asthma
2012-10-15
LOS ANGELES (Oct. 15, 2012) – Currently, there are approximately 25 million people in the United States who suffer from the lifelong effects of asthma – wheezing, breathlessness, tightness in the chest, coughing – and the numbers are rising each year. According to the Centers for Disease Control and Prevention (CDC), the number of people in the United States diagnosed with asthma grew by 4.3 million from 2001 to 2009. Approximately 1 in 10 children and 1 in 12 adults suffer from asthma; the numbers are even higher among racial/ethnic groups, with 1 in 6 children in the ...
Urgent need for tuberculosis vaccines; experts report progress, obstacles in growing drug resistance
2012-10-15
Contact: Coimbra Sirica
csirica@burnesscommunications.com
44-743-538-4915
Burness Communications
Annmarie Leadman
aleadman@aeras.org
301-332-8252
Aeras
Urgent need for tuberculosis vaccines; experts report progress, obstacles in growing drug resistance
As World Health Organization prepares to release report on global TB incidence, researchers say UK at forefront of efforts to develop critical medical tools
London (October 15, 2012) – Drawing on recent findings of a significant rise in cases of drug-resistant tuberculosis in the UK and globally, top TB researchers ...
LAST 30 PRESS RELEASES:
Plant doctor: An AI system that watches over urban trees without touching a leaf
Study tracks chromium chemistry in irradiated molten salts
Scientists: the beautiful game is a silver bullet for global health
Being physically active, even just a couple of days a week, may be key to better health
High-fat diet promote breast cancer metastasis in animal models
A router for photons
Nurses and AI collaborate to save lives, reduce hospital stays
Multi-resistance in bacteria predicted by AI model
Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection
Sensing sickness
Cost to build multifamily housing in California more than twice as high as in Texas
Program takes aim at drinking, unsafe sex, and sexual assault on college campuses
Inability to pay for healthcare reaches record high in U.S.
Science ‘storytelling’ urgently needed amid climate and biodiversity crisis
KAIST Develops Retinal Therapy to Restore Lost Vision
Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response
Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid
Low LDL cholesterol levels linked to reduced risk of dementia
Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients
Almost one in ten people surveyed report having been harmed by the NHS in the last three years
Enhancing light control with complex frequency excitations
New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients
New insight into factors associated with a common disease among dogs and humans
Illuminating single atoms for sustainable propylene production
New study finds Rocky Mountain snow contamination
Study examines lactation in critically ill patients
UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award
Doubling down on metasurfaces
New Cedars-Sinai study shows how specialized diet can improve gut disorders
Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana
[Press-News.org] An immunosuppressive drug could delay the onset of neurodegenerative diseasesRapamycin, a drug used to prevent rejection in transplants, could delay the onset of diseases such as Alzheimer's or Parkinson's